Articles with public access mandates - Sara HamisLearn more
Available somewhere: 9
Iterative community-driven development of a SARS-CoV-2 tissue simulator
M Getz, Y Wang, G An, M Asthana, A Becker, C Cockrell, N Collier, ...
BioRxiv, 2020.04. 02.019075, 2020
Mandates: US National Science Foundation, US National Institutes of Health, Natural …
Predicting and elucidating the post-printing behavior of 3D printed cancer cells in hydrogel structures by integrating in-vitro and in-silico experiments
D Mohammadrezaei, N Moghimi, S Vandvajdi, G Powathil, S Hamis, ...
Scientific Reports 13 (1), 1211, 2023
Mandates: Canadian Institutes of Health Research
Uncertainty and sensitivity analyses methods for agent-based mathematical models: An introductory review
S Hamis, S Stratiev, GG Powathil
THE PHYSICS OF CANCER: Research Advances, 1-37, 2021
Mandates: UK Medical Research Council, UK Science and Technology Facilities Council
Combining hypoxia-activated prodrugs and radiotherapy in silico: Impact of treatment scheduling and the intra-tumoural oxygen landscape
S Hamis, M Kohandel, LJ Dubois, A Yaromina, P Lambin, GG Powathil
PLoS computational biology 16 (8), e1008041, 2020
Mandates: Canadian Institutes of Health Research, UK Medical Research Council …
Targeting Cellular DNA Damage Responses in Cancer: An In Vitro-Calibrated Agent-Based Model Simulating Monolayer and Spheroid Treatment Responses to ATR-Inhibiting Drugs
Hamis, S., Yates, J., Chaplain, M.A.J., Powathil, G.G.
Bull Math Biol 83 (103), 2021
Mandates: UK Medical Research Council
Quantifying ERK activity in response to inhibition of the BRAFV600E-MEK-ERK cascade using mathematical modelling
S Hamis, Y Kapelyukh, A McLaren, CJ Henderson, CR Wolf, ...
British Journal of Cancer, 2021
Mandates: UK Medical Research Council
Spatial cumulant models enable spatially informed treatment strategies and analysis of local interactions in cancer systems
S Hamis, P Somervuo, JA Ågren, DS Tadele, J Kesseli, JG Scott, M Nykter, ...
Journal of Mathematical Biology 86 (5), 68, 2023
Mandates: US National Institutes of Health, Academy of Finland, European Commission …
Growth rate-driven modelling reveals how phenotypic adaptation drives drug resistance in BRAFV600E-mutant melanoma
S Hamis, AP Browning, AL Jenner, C Villa, P Maini, T Cassidy
bioRxiv, 2024.08. 14.607616, 2024
Mandates: European Commission
Simulations probe the role of space in the interplay between drug-sensitive and drug-resistant cancer cells
K Pugh, RDO Jones, G Powathil, S Hamis
biorxiv, 2024
Mandates: UK Engineering and Physical Sciences Research Council
Publication and funding information is determined automatically by a computer program